1. Home
  2. ME vs ENX Comparison

ME vs ENX Comparison

Compare ME & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ME
  • ENX
  • Stock Information
  • Founded
  • ME 2006
  • ENX 2002
  • Country
  • ME United States
  • ENX United States
  • Employees
  • ME N/A
  • ENX N/A
  • Industry
  • ME Precision Instruments
  • ENX Finance/Investors Services
  • Sector
  • ME Health Care
  • ENX Finance
  • Exchange
  • ME Nasdaq
  • ENX Nasdaq
  • Market Cap
  • ME 168.9M
  • ENX 178.4M
  • IPO Year
  • ME N/A
  • ENX N/A
  • Fundamental
  • Price
  • ME $0.34
  • ENX $10.03
  • Analyst Decision
  • ME Hold
  • ENX
  • Analyst Count
  • ME 1
  • ENX 0
  • Target Price
  • ME $0.47
  • ENX N/A
  • AVG Volume (30 Days)
  • ME 2.4M
  • ENX 25.4K
  • Earning Date
  • ME 11-06-2024
  • ENX 01-01-0001
  • Dividend Yield
  • ME N/A
  • ENX 3.94%
  • EPS Growth
  • ME N/A
  • ENX N/A
  • EPS
  • ME N/A
  • ENX 0.16
  • Revenue
  • ME $199,188,000.00
  • ENX N/A
  • Revenue This Year
  • ME $0.05
  • ENX N/A
  • Revenue Next Year
  • ME $17.98
  • ENX N/A
  • P/E Ratio
  • ME N/A
  • ENX $61.00
  • Revenue Growth
  • ME N/A
  • ENX N/A
  • 52 Week Low
  • ME $0.29
  • ENX $7.84
  • 52 Week High
  • ME $1.12
  • ENX $10.07
  • Technical
  • Relative Strength Index (RSI)
  • ME 52.28
  • ENX 61.72
  • Support Level
  • ME $0.29
  • ENX $9.86
  • Resistance Level
  • ME $0.32
  • ENX $10.09
  • Average True Range (ATR)
  • ME 0.02
  • ENX 0.07
  • MACD
  • ME 0.01
  • ENX 0.01
  • Stochastic Oscillator
  • ME 86.78
  • ENX 82.61

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value

Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.

Share on Social Networks: